TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23908084

Group type: EXPERIMENTAL
Intervention: 50 mg flurbiprofen axetil intravenously 15 minutes before surgical incision and 6 hours later (group F)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous 5 mL intralipid as a control (group C)
Number of subjects: 60
Study: 21983214

Group type: EXPERIMENTAL
Intervention: MF-59-adjuvanted influenza vaccine (Novartis Vaccines)
Number of subjects: 4707

Group type: COMPARATOR
Intervention: Trivalent inactivated influenza vaccine subunit (GSK)
Number of subjects: 4707

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 4707
Study: 19552905

Group type: EXPERIMENTAL
Intervention: Interactive computer assisted instruction (ICAI)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Instructor-led videotape learning program (IVLP)
Number of subjects: 84
Study: 17118810

Group type: EXPERIMENTAL
Intervention: Questionnaires measuring subjective craving (Visual Analogue Scale - VAS)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Questionnaires measuring anxiety and depression states
Number of subjects: 53
Study: 15302236

Group type: EXPERIMENTAL
Intervention: HIV positive patients
Number of subjects: 27

Group type: COMPARATOR
Intervention: HIV negative patients
Number of subjects: 27
Study: 11777291

Group type: EXPERIMENTAL
Intervention: Simvastatin 120 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Simvastatin 80 mg
Number of subjects: 22
Study: 10190709

Group type: EXPERIMENTAL
Intervention: Topical ofloxacin 0.3% (OFLX), 0.25 ml topically bid for 10 days
Number of subjects: 286

Group type: COMPARATOR
Intervention: Systemic amoxicillin/clavulanate (AUG), 40 mg/kg per day for 10 days
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Topical ofloxacin 0.3% (OFLX)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Systemic amoxicillin/clavulanate (AUG)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Topical ofloxacin 0.3% (OFLX) and Systemic amoxicillin/clavulanate (AUG)
Number of subjects: 286
Study: 7845792

Group type: EXPERIMENTAL
Intervention: ACT sensor mode
Number of subjects: 6
Study: 3052183

Group type: COMPARATOR
Intervention: Captopril (C) 25 mg tid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nicardipine (N) 20 mg tid
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 10
Study: 29292054

Group type: EXPERIMENTAL
Intervention: Beclomethasone 100 mcg plus Formoterol 6 mcg (BDP/F)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Fluticasone 125 mcg plus Salmeterol 25 mcg (FP/S)
Number of subjects: 253
Study: 28895794

Group type: EXPERIMENTAL
Intervention: Synbiotics (Probinul Neutro, CadiGroup, Rome, Italy), 5 g powder packets dissolved in water three times a day for 30 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo, taken at home for 30 days
Number of subjects: 36
Study: 26146240

Group type: EXPERIMENTAL
Intervention: Flinders Program plus usual care
Number of subjects: 231

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 231
Study: 23715125

Group type: EXPERIMENTAL
Intervention: Phosphorus mobilization clearance
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Postdialysis central distribution volume
Number of subjects: 774
Study: 21317794

Group type: EXPERIMENTAL
Intervention: TBR-652 25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TBR-652 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TBR-652 75 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TBR-652 150 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19268976

Group type: EXPERIMENTAL
Intervention: Levodopa combined with language therapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 16813616

Group type: EXPERIMENTAL
Intervention: Prolene Hernia System (PHS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Lichtenstein Method
Number of subjects: 64
Study: 12775198

Group type: EXPERIMENTAL
Intervention: Supervised physical therapy with a home program
Number of subjects: 84

Group type: COMPARATOR
Intervention: Home program alone
Number of subjects: 84
Study: 10843028

Group type: EXPERIMENTAL
Intervention: Intramuscular ceftriaxone 50 mg/kg
Number of subjects: 172

Group type: COMPARATOR
Intervention: No second dose of ceftriaxone
Number of subjects: 172
Study: 9062488

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 7934009

Group type: EXPERIMENTAL
Intervention: Vigorous arm swing with hand-held towels (VAST)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal arm swing (NAS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Vigorous arm swing (VAS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Vigorous arm swing at NAS heart rate (VNH)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Vigorous arm swing with hand-held towels at NAS heart rate (VTNH)
Number of subjects: 16
Study: 2467496

Group type: EXPERIMENTAL
Intervention: Acrivastine 8 mg t.d.s.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hydroxyzine hydrochloride 20 mg t.d.s.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30720792

Group type: EXPERIMENTAL
Intervention: Dementia Care in Hospitals Program (DCHP) - hospital-wide CI awareness and support education, screening for all patients aged 65+, bedside alert (Cognitive Impairment Identifier)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual hospital care (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dementia Care in Hospitals Program (DCHP)
Number of subjects: 0
Study: 27544607

Group type: EXPERIMENTAL
Intervention: Drug-eluting stent (DES) implantation
Number of subjects: 97
Study: 25535691

Group type: EXPERIMENTAL
Intervention: PWI (+)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (PWI (‐))
Number of subjects: 120

Group type: COMPARATOR
Intervention: PWI (+) and Control (PWI (‐))
Number of subjects: 120
Study: 23558843

Group type: EXPERIMENTAL
Intervention: S(+)‐ketamine
Number of subjects: 140

Group type: COMPARATOR
Intervention: ropivacaine
Number of subjects: 140
Study: 20092882

Group type: EXPERIMENTAL
Intervention: Combination therapy (lithium plus valproate)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Lithium monotherapy
Number of subjects: 330

Group type: COMPARATOR
Intervention: Valproate monotherapy
Number of subjects: 330
Study: 18447213

Group type: EXPERIMENTAL
Intervention: Tiaoshen Fuyin acupuncture therapy combined with language training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple language training
Number of subjects: 60
Study: 16628416

Group type: EXPERIMENTAL
Intervention: 0.1% timolol hydrogel
Number of subjects: 25

Group type: COMPARATOR
Intervention: 0.5% aqueous timolol
Number of subjects: 25
Study: 12711947

Group type: EXPERIMENTAL
Intervention: Internal mammary vessels
Number of subjects: 100

Group type: COMPARATOR
Intervention: Thoracodorsal vessels
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 10750003

Group type: EXPERIMENTAL
Intervention: Femoral nerve block (FNB) with 0.25% bupivacaine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Femoral nerve block (FNB)
Number of subjects: 61
Study: 8941480

Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 12

Group type: COMPARATOR
Intervention: Regular insulin
Number of subjects: 12
Study: 1524913

Group type: EXPERIMENTAL
Intervention: ciprofloxacin (1 g/day)
Number of subjects: 230

Group type: COMPARATOR
Intervention: co‐trimoxazole (1920 mg/day) plus colistin (800 mg/day)
Number of subjects: 230
Study: 3516703

Group type: EXPERIMENTAL
Intervention: Pirmenol (50 mg intravenous injection followed by 2.5 mg min‐1 infusion)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lidocaine (75 mg injection followed by 3 mg min‐1 infusion)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 29686027

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 3977

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3977
Study: 27257049

Group type: EXPERIMENTAL
Intervention: Sequential Therapy (ST)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Concomitant Therapy (CT)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Triple Therapy (TT)
Number of subjects: 517
Study: 24102806

Group type: EXPERIMENTAL
Intervention: Autologous cord blood infusion
Number of subjects: 17
Study: 22524329

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate
Number of subjects: 62

Group type: COMPARATOR
Intervention: Low-intensity laser
Number of subjects: 62
Study: 20884874

Group type: EXPERIMENTAL
Intervention: Fasting (>18 hours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholestyramine (bile acid-binding resin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Growth hormone (increased during fasting)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diurnal rhythm of PCSK9
Number of subjects: 0
Study: 18559469

Group type: EXPERIMENTAL
Intervention: Radiofrequency microtenotomy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Extensor tendon release and repair
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dynamic infrared thermography (DIRT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: DIRT
Number of subjects: 24
Study: 16756147

Group type: EXPERIMENTAL
Intervention: Granulocyte colony stimulating factor (G‐CSF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 12548215

Group type: EXPERIMENTAL
Intervention: Cardiotocography plus ST analysis
Number of subjects: 4966

Group type: COMPARATOR
Intervention: Cardiotocography only
Number of subjects: 4966
Study: 10486390

Group type: COMPARATOR
Intervention: Interferon beta-1a (INFbeta-1a) 22 microg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon beta-1a (INFbeta-1a) 44 microg
Number of subjects: 0
Study: 8898485

Group type: EXPERIMENTAL
Intervention: Professional therapists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonprofessional therapists
Number of subjects: 0
Study: 1505413

Group type: EXPERIMENTAL
Intervention: Dapsone-pyrimethamine (50-100 mg dapsone and 6.25-12.5 mg pyrimethamine weekly)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study: 6415016

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 5) ran at their highest tolerable volitional intensity for 20‐45 min during the recovery period
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rest group (n = 5) performed no physical activity
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 5)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rest group (n = 5)
Number of subjects: 10
Study: 29987705

Group type: EXPERIMENTAL
Intervention: Intraoperative 360° prophylactic endolaser photocoagulation (Group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Endolaser only to the retinal breaks (Group B)
Number of subjects: 50
Study: 30532180

Group type: EXPERIMENTAL
Intervention: Unanticipated questions regarding planning of a task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unanticipated questions regarding spatial and temporal details
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unanticipated questions technique overall
Number of subjects: 0
Study: 27406897

Group type: EXPERIMENTAL
Intervention: Axillary surgery (specific intervention details not provided)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sentinel lymph node biopsy alone (control group)
Number of subjects: 0
Study: 24192055

Group type: EXPERIMENTAL
Intervention: cisplatin-pemetrexed (CPx)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: cisplatin-vinorelbine (CVb)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 132
Study: 23213757

Group type: EXPERIMENTAL
Intervention: Epley's manoeuvre plus labyrinthine sedative (Betahistine mesilate, flunarizine hydrochloride, Ginkgo biloba)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Epley's manoeuvre alone
Number of subjects: 84
Study: 20849630

Group type: EXPERIMENTAL
Intervention: Psychotherapeutic intervention (8 sessions of 90 minutes in groups)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 150
Study: 18206038

Group type: EXPERIMENTAL
Intervention: Normotensive group (n = 26)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Hypertensive group (n = 28)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study: 16366235

Group type: EXPERIMENTAL
Intervention: Joint symbolic dynamics (JSD) analysis of heart rate and blood pressure in DCM
Number of subjects: 75

Group type: COMPARATOR
Intervention: Healthy controls, n = 75
Number of subjects: 75
Study: 14658377

Group type: EXPERIMENTAL
Intervention: American pitchers
Number of subjects: 19

Group type: COMPARATOR
Intervention: Korean pitchers
Number of subjects: 19
Study: 9476744

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR 75-225 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8549941

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cholestyramine 4 g twice daily
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combination of simvastatin and cholestyramine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cholestyramine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Simvastatin and cholestyramine
Number of subjects: 8
Study: 2171630

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 42976

Group type: EXPERIMENTAL
Intervention: Mouth and throat disinfectant lozenges (sugar-containing)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sugar-free mouth and throat disinfectant lozenge
Number of subjects: 10
Study: 31552551

Group type: EXPERIMENTAL
Intervention: Vortioxetine (10 mg single dose, 10 mg and 20 mg multiple daily doses)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Vortioxetine
Number of subjects: 186
Study: 28373452

Group type: EXPERIMENTAL
Intervention: TACE using drug-eluting beads (DEBs) loaded with doxorubicin
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: TACE using polyethylene glycol drug-elutable microspheres (PEG) loaded with doxorubicin
Number of subjects: 127
Study: 25812465

Group type: EXPERIMENTAL
Intervention: Educational plus interactive text message reminders
Number of subjects: 5462

Group type: COMPARATOR
Intervention: Educational‐only text message reminders
Number of subjects: 5462

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5462
Study: 23900878

Group type: EXPERIMENTAL
Intervention: Macitentan (1-30 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 22338349

Group type: EXPERIMENTAL
Intervention: Psychological skills training (PST)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no training beyond normal curriculum)
Number of subjects: 65
Study: 19815198

Group type: EXPERIMENTAL
Intervention: Modified natural cycles with hCG
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controlled ovarian hyperstimulation cycles
Number of subjects: 0
Study: 17493004

Group type: EXPERIMENTAL
Intervention: Curcumin 30 mg b.i.d., bovine lactoferrin 100 mg b.i.d., N-acetylcysteine 600 mg b.i.d., pantoprazole 20 mg b.i.d.
Number of subjects: 25
Study: 15833589

Group type: EXPERIMENTAL
Intervention: Cortisol (0.5 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cortisol (0.2 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cocaine (0.2 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 12042201

Group type: EXPERIMENTAL
Intervention: Olanzapine plus fluoxetine (10 mg/day olanzapine, 20 mg/day fluoxetine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Olanzapine plus placebo (10 mg/day olanzapine, placebo)
Number of subjects: 30
Study: 9701717

Group type: EXPERIMENTAL
Intervention: Chemical intolerance (CI) group
Number of subjects: 35

Group type: COMPARATOR
Intervention: Depressives without CI group
Number of subjects: 35

Group type: COMPARATOR
Intervention: Normals group
Number of subjects: 35
Study: 7701171

Group type: EXPERIMENTAL
Intervention: Hyperventilation
Number of subjects: 10
Study: 2652217

Group type: EXPERIMENTAL
Intervention: Cimetidine (CMT) 400 mg/night
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ranitidine (RNT) 150 mg/night
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cimetidine (CMT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ranitidine (RNT)
Number of subjects: 60
Study: 1100308

Group type: EXPERIMENTAL
Intervention: Intramuscular phenytoin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous phenytoin
Number of subjects: 12
Study: 31706719

Group type: EXPERIMENTAL
Intervention: 70-gene signature (MammaPrint®)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 21-gene Recurrence Score (RS) assay (Oncotype DX®)
Number of subjects: 3
Study: 27925359

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (AEI) for 3 months
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (CG) received WCRF/AICR recommendations to be physically active
Number of subjects: 38
Study: 28191694

Group type: EXPERIMENTAL
Intervention: RCT sample treatment effects (weighted)
Number of subjects: 3592
Study: 26517756

Group type: EXPERIMENTAL
Intervention: Intravaginal 0.50% DHEA (prasterone)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 23339050

Group type: EXPERIMENTAL
Intervention: NYU Caregiver Intervention (NYUCI‐AC)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Contact control group
Number of subjects: 107
Study: 21174209

Group type: EXPERIMENTAL
Intervention: Cold pressor test (CPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 0
Study: 18806550

Group type: EXPERIMENTAL
Intervention: Experimental group (E, played in the game; n = 14)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (C, did not participate in the game; n = 10)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Experimental group (E)
Number of subjects: 24
Study: 16800989

Group type: EXPERIMENTAL
Intervention: Xiaoyao Nose Drops (XYND)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 12499043

Group type: EXPERIMENTAL
Intervention: Medial cerebellar rTMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10827334

Group type: EXPERIMENTAL
Intervention: 1-implant group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 2-implant group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nestorone(R) implants
Number of subjects: 120
Study: 8624759

Group type: EXPERIMENTAL
Intervention: Pneumocystis carinii pneumonia (PCP)
Number of subjects: 1530

Group type: EXPERIMENTAL
Intervention: Mycobacterium avium complex (MAC)
Number of subjects: 1530

Group type: EXPERIMENTAL
Intervention: Cytomegalovirus (CMV)
Number of subjects: 1530

Group type: EXPERIMENTAL
Intervention: Systemic mycosis
Number of subjects: 1530
Study: 1411840

Group type: EXPERIMENTAL
Intervention: Condom Skills
Number of subjects: 903

Group type: EXPERIMENTAL
Intervention: Social Influences
Number of subjects: 903

Group type: EXPERIMENTAL
Intervention: Distribution
Number of subjects: 903

Group type: COMPARATOR
Intervention: Control (male subjects)
Number of subjects: 903

Group type: EXPERIMENTAL
Intervention: Social Influences (female patients)
Number of subjects: 903
Study: 6226224

Group type: COMPARATOR
Intervention: Pyridostigmine with placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pyridostigmine with ipratropium bromide (72 micrograms)
Number of subjects: 21
Study: 30957981

Group type: EXPERIMENTAL
Intervention: High-frequency dTMS (18 Hz)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Low-frequency dTMS (1 Hz)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 33
Study: 29500848

Group type: EXPERIMENTAL
Intervention: High UFP-emitting acrylonitrile butadiene styrene (ABS)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low-emitting polylactic acid (PLA)
Number of subjects: 26
Study: 26916733

Group type: EXPERIMENTAL
Intervention: MDCO-216 (5, 10, 20, 30, and 40 mg/kg) infused over 2 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MDCO-216 (high doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MDCO-216
Number of subjects: 0
Study: 24441216

Group type: COMPARATOR
Intervention: Metronome
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Synchronous music
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Asynchronous music
Number of subjects: 23
Study: 22331147

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB) - 3 monthly injections of 1.25 mg
Number of subjects: 86

Group type: COMPARATOR
Intervention: Intravitreal triamcinolone (IVT) - 2 injections of 2 mg 2 months apart
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Intravitreal triamcinolone (IVT)
Number of subjects: 86
Study: 20204916

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Relapse Prevention (MBRP)
Number of subjects: 44
Study: 17497754

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analytical method (IPLC/FLD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sample preparation (liquid‐liquid extraction)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isocratic ion pair elution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluorescence detection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Large sample volume (250 microL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linear response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low limits of quantification (LLOQ)
Number of subjects: 0
Study: 16198881

Group type: EXPERIMENTAL
Intervention: Apical long-axis (APLAX) view
Number of subjects: 100

Group type: COMPARATOR
Intervention: Two-chamber (2CH) view
Number of subjects: 100
Study: 11862975

Group type: COMPARATOR
Intervention: Chronic alacepril treatment (12 weeks)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Acute alacepril treatment
Number of subjects: 4
Study: 10416313

Group type: EXPERIMENTAL
Intervention: Heparin therapy
Number of subjects: 25